PROTACs in 2025: from the laboratory concept to clinical breakthrough
Future Medicinal Chemistry · 03.05.2026 · 18 (9) · 1007-1009
DOI: 10.1080/17568919.2026.2655682 ↗Kurz gefasst
Editorial in der Zeitschrift Future Medicinal Chemistry, online erschienen am 06.04.2026. Verfasst von Yan Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan, Training Program for Young Key Teachers of Colleges and Universities in Henan Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan
- Training Program for Young Key Teachers of Colleges and Universities in Henan Province
Zitieren
APA
Xu, Y., Li, X. Y., Song, J., & Zhang, S. Y. (2026). PROTACs in 2025: from the laboratory concept to clinical breakthrough. Future Medicinal Chemistry, 18(9), 1007-1009. https://doi.org/10.1080/17568919.2026.2655682
Vancouver
Xu Y, Li XY, Song J, Zhang SY. PROTACs in 2025: from the laboratory concept to clinical breakthrough. Future Medicinal Chemistry. 2026;18(9):1007-1009. doi:10.1080/17568919.2026.2655682
BibTeX
@article{Xu2026,
author = {Xu, Yan and Li, Xin-Yu and Song, Jian and Zhang, Sai-Yang},
title = {PROTACs in 2025: from the laboratory concept to clinical breakthrough},
journal = {Future Medicinal Chemistry},
year = {2026},
volume = {18},
number = {9},
pages = {1007--1009},
doi = {10.1080/17568919.2026.2655682}
}
EUVIMED